Heart transplantation in mildly diabetic patients

Ezio Faglia, Fabrizio Favales, Ester Mazzola, Gianluigi Pizzi, Renata De Maria, Maurizio Mangiavacchi, Edoardo Gronda, Angelo Caroli, Meri S. Zaina

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

From 1985 to 1989, 67 heart transplantations were performed in our hospital, 6 of them in noninsulin-dependent (type II) diabetic patients. Six pretransplantation type II diabetic male heart recipients (mean ± SD age 50.0 ± 7.3 yr) were compared with 61 nondiabetic recipients (mean age 44.5 ± 11.0 yr; 55 men, 6 women) to define whether a different posttransplantation prognosis may be caused by pretransplantation diabetes. Before transplantation, all diabetic recipients (3 newly diagnosed and 3 with diabetes duration of 5, 6, and 12 yr, respectively) were in good glycemic control (mean fasting blood glucose 7.95 ± 1.62 mM, mean HbA1c 7.6 ± 0.2%). None had ocular or renal microangiopathic complications, 5 were treated only with diet, and 1 was treated with oral hypoglycemic agents. All recipients were treated with the same immunosuppressive protocol (cyclosporin, prednisone, and since 1986, azathioprine and antilymphocyte globulin), and mean dose and blood levels of cyclosporin were not significantly different between diabetic and nondiabetic recipients. After heart transplantation (mean follow-up 558 ± 340 days in diabetic and 379 ± 338 in nondiabetic recipients), the mortality rate and complications (i.e., rejection episodes, supplementary immunosuppressive treatments, major and minor infections, arterial hypertension, and graft atherosclerosis) showed no significant differences except for the more frequent arterial hypertension in diabetic recipients (P <0.05), although pretransplantation incidence of hypertension was lower in diabetic candidates. Even during immunosuppressive treatment, including corticosteroids, diabetic recipients had good metabolic control (mean fasting blood glucose 6.32 ± 1.96 mM, mean HbA1c 5.3 ± 0.5% at the 6th mo). Three recipients were treated with insulin and/or oral hypoglycemic agents, and 1 recipient was treated with diet only. Serum cholesterol, triglycerides, and creatinine levels did not vary significantly between the two groups in posttransplantation follow-up. After heart transplantation, pretransplantation diabetic recipients in good metabolic control and without microangiopathic complications had the same prognosis in this series as nondiabetic recipients at this stage of follow-up.

Original languageEnglish
Pages (from-to)740-742
Number of pages3
JournalDiabetes
Volume39
Issue number6
Publication statusPublished - Jun 1990

Fingerprint

Heart Transplantation
Immunosuppressive Agents
Hypertension
Hypoglycemic Agents
Cyclosporine
Blood Glucose
Fasting
Diet
Antilymphocyte Serum
Azathioprine
Prednisone
Creatinine
Atherosclerosis
Adrenal Cortex Hormones
Triglycerides
Transplantation
Cholesterol
Insulin
Transplants
Kidney

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Faglia, E., Favales, F., Mazzola, E., Pizzi, G., De Maria, R., Mangiavacchi, M., ... Zaina, M. S. (1990). Heart transplantation in mildly diabetic patients. Diabetes, 39(6), 740-742.

Heart transplantation in mildly diabetic patients. / Faglia, Ezio; Favales, Fabrizio; Mazzola, Ester; Pizzi, Gianluigi; De Maria, Renata; Mangiavacchi, Maurizio; Gronda, Edoardo; Caroli, Angelo; Zaina, Meri S.

In: Diabetes, Vol. 39, No. 6, 06.1990, p. 740-742.

Research output: Contribution to journalArticle

Faglia, E, Favales, F, Mazzola, E, Pizzi, G, De Maria, R, Mangiavacchi, M, Gronda, E, Caroli, A & Zaina, MS 1990, 'Heart transplantation in mildly diabetic patients', Diabetes, vol. 39, no. 6, pp. 740-742.
Faglia E, Favales F, Mazzola E, Pizzi G, De Maria R, Mangiavacchi M et al. Heart transplantation in mildly diabetic patients. Diabetes. 1990 Jun;39(6):740-742.
Faglia, Ezio ; Favales, Fabrizio ; Mazzola, Ester ; Pizzi, Gianluigi ; De Maria, Renata ; Mangiavacchi, Maurizio ; Gronda, Edoardo ; Caroli, Angelo ; Zaina, Meri S. / Heart transplantation in mildly diabetic patients. In: Diabetes. 1990 ; Vol. 39, No. 6. pp. 740-742.
@article{2dd815eae6a44821a2d66773df02db3b,
title = "Heart transplantation in mildly diabetic patients",
abstract = "From 1985 to 1989, 67 heart transplantations were performed in our hospital, 6 of them in noninsulin-dependent (type II) diabetic patients. Six pretransplantation type II diabetic male heart recipients (mean ± SD age 50.0 ± 7.3 yr) were compared with 61 nondiabetic recipients (mean age 44.5 ± 11.0 yr; 55 men, 6 women) to define whether a different posttransplantation prognosis may be caused by pretransplantation diabetes. Before transplantation, all diabetic recipients (3 newly diagnosed and 3 with diabetes duration of 5, 6, and 12 yr, respectively) were in good glycemic control (mean fasting blood glucose 7.95 ± 1.62 mM, mean HbA1c 7.6 ± 0.2{\%}). None had ocular or renal microangiopathic complications, 5 were treated only with diet, and 1 was treated with oral hypoglycemic agents. All recipients were treated with the same immunosuppressive protocol (cyclosporin, prednisone, and since 1986, azathioprine and antilymphocyte globulin), and mean dose and blood levels of cyclosporin were not significantly different between diabetic and nondiabetic recipients. After heart transplantation (mean follow-up 558 ± 340 days in diabetic and 379 ± 338 in nondiabetic recipients), the mortality rate and complications (i.e., rejection episodes, supplementary immunosuppressive treatments, major and minor infections, arterial hypertension, and graft atherosclerosis) showed no significant differences except for the more frequent arterial hypertension in diabetic recipients (P <0.05), although pretransplantation incidence of hypertension was lower in diabetic candidates. Even during immunosuppressive treatment, including corticosteroids, diabetic recipients had good metabolic control (mean fasting blood glucose 6.32 ± 1.96 mM, mean HbA1c 5.3 ± 0.5{\%} at the 6th mo). Three recipients were treated with insulin and/or oral hypoglycemic agents, and 1 recipient was treated with diet only. Serum cholesterol, triglycerides, and creatinine levels did not vary significantly between the two groups in posttransplantation follow-up. After heart transplantation, pretransplantation diabetic recipients in good metabolic control and without microangiopathic complications had the same prognosis in this series as nondiabetic recipients at this stage of follow-up.",
author = "Ezio Faglia and Fabrizio Favales and Ester Mazzola and Gianluigi Pizzi and {De Maria}, Renata and Maurizio Mangiavacchi and Edoardo Gronda and Angelo Caroli and Zaina, {Meri S.}",
year = "1990",
month = "6",
language = "English",
volume = "39",
pages = "740--742",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "6",

}

TY - JOUR

T1 - Heart transplantation in mildly diabetic patients

AU - Faglia, Ezio

AU - Favales, Fabrizio

AU - Mazzola, Ester

AU - Pizzi, Gianluigi

AU - De Maria, Renata

AU - Mangiavacchi, Maurizio

AU - Gronda, Edoardo

AU - Caroli, Angelo

AU - Zaina, Meri S.

PY - 1990/6

Y1 - 1990/6

N2 - From 1985 to 1989, 67 heart transplantations were performed in our hospital, 6 of them in noninsulin-dependent (type II) diabetic patients. Six pretransplantation type II diabetic male heart recipients (mean ± SD age 50.0 ± 7.3 yr) were compared with 61 nondiabetic recipients (mean age 44.5 ± 11.0 yr; 55 men, 6 women) to define whether a different posttransplantation prognosis may be caused by pretransplantation diabetes. Before transplantation, all diabetic recipients (3 newly diagnosed and 3 with diabetes duration of 5, 6, and 12 yr, respectively) were in good glycemic control (mean fasting blood glucose 7.95 ± 1.62 mM, mean HbA1c 7.6 ± 0.2%). None had ocular or renal microangiopathic complications, 5 were treated only with diet, and 1 was treated with oral hypoglycemic agents. All recipients were treated with the same immunosuppressive protocol (cyclosporin, prednisone, and since 1986, azathioprine and antilymphocyte globulin), and mean dose and blood levels of cyclosporin were not significantly different between diabetic and nondiabetic recipients. After heart transplantation (mean follow-up 558 ± 340 days in diabetic and 379 ± 338 in nondiabetic recipients), the mortality rate and complications (i.e., rejection episodes, supplementary immunosuppressive treatments, major and minor infections, arterial hypertension, and graft atherosclerosis) showed no significant differences except for the more frequent arterial hypertension in diabetic recipients (P <0.05), although pretransplantation incidence of hypertension was lower in diabetic candidates. Even during immunosuppressive treatment, including corticosteroids, diabetic recipients had good metabolic control (mean fasting blood glucose 6.32 ± 1.96 mM, mean HbA1c 5.3 ± 0.5% at the 6th mo). Three recipients were treated with insulin and/or oral hypoglycemic agents, and 1 recipient was treated with diet only. Serum cholesterol, triglycerides, and creatinine levels did not vary significantly between the two groups in posttransplantation follow-up. After heart transplantation, pretransplantation diabetic recipients in good metabolic control and without microangiopathic complications had the same prognosis in this series as nondiabetic recipients at this stage of follow-up.

AB - From 1985 to 1989, 67 heart transplantations were performed in our hospital, 6 of them in noninsulin-dependent (type II) diabetic patients. Six pretransplantation type II diabetic male heart recipients (mean ± SD age 50.0 ± 7.3 yr) were compared with 61 nondiabetic recipients (mean age 44.5 ± 11.0 yr; 55 men, 6 women) to define whether a different posttransplantation prognosis may be caused by pretransplantation diabetes. Before transplantation, all diabetic recipients (3 newly diagnosed and 3 with diabetes duration of 5, 6, and 12 yr, respectively) were in good glycemic control (mean fasting blood glucose 7.95 ± 1.62 mM, mean HbA1c 7.6 ± 0.2%). None had ocular or renal microangiopathic complications, 5 were treated only with diet, and 1 was treated with oral hypoglycemic agents. All recipients were treated with the same immunosuppressive protocol (cyclosporin, prednisone, and since 1986, azathioprine and antilymphocyte globulin), and mean dose and blood levels of cyclosporin were not significantly different between diabetic and nondiabetic recipients. After heart transplantation (mean follow-up 558 ± 340 days in diabetic and 379 ± 338 in nondiabetic recipients), the mortality rate and complications (i.e., rejection episodes, supplementary immunosuppressive treatments, major and minor infections, arterial hypertension, and graft atherosclerosis) showed no significant differences except for the more frequent arterial hypertension in diabetic recipients (P <0.05), although pretransplantation incidence of hypertension was lower in diabetic candidates. Even during immunosuppressive treatment, including corticosteroids, diabetic recipients had good metabolic control (mean fasting blood glucose 6.32 ± 1.96 mM, mean HbA1c 5.3 ± 0.5% at the 6th mo). Three recipients were treated with insulin and/or oral hypoglycemic agents, and 1 recipient was treated with diet only. Serum cholesterol, triglycerides, and creatinine levels did not vary significantly between the two groups in posttransplantation follow-up. After heart transplantation, pretransplantation diabetic recipients in good metabolic control and without microangiopathic complications had the same prognosis in this series as nondiabetic recipients at this stage of follow-up.

UR - http://www.scopus.com/inward/record.url?scp=0025339635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025339635&partnerID=8YFLogxK

M3 - Article

C2 - 2189766

AN - SCOPUS:0025339635

VL - 39

SP - 740

EP - 742

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 6

ER -